Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?
Bryan J. Winn
Topics & Concepts
ARDSMedicineLungRespiratory distressInsulin-like growth factorDiffuse alveolar damageInternal medicineGrowth factorPathologyImmunologyReceptorAnesthesiaAcute respiratory distressOphthalmology and Eye DisordersRespiratory Support and MechanismsNeuroblastoma Research and Treatments